version 16 1 statacorp lp (STATA Corporation)
STATA Corporation is a verified supplier 
99
Structured Review
STATA Corporation
version 16 1 statacorp lp
Version 16 1 Statacorp Lp, supplied by STATA Corporation, used in various techniques. Bioz Stars score: 99/100, based on 35576 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/stata+statacorp/STATA+16%2E0/pm41605729-96-6-5
Average 99 stars, based on 35576 article reviews
Version 16 1 Statacorp Lp, supplied by STATA Corporation, used in various techniques. Bioz Stars score: 99/100, based on 35576 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/stata+statacorp/STATA+16%2E0/pm41605729-96-6-5
Average 99 stars, based on 35576 article reviews
version 16 1 statacorp lp - by Bioz Stars,
2026-10
99/100 stars
Images
Related Articles
other:Article Title: The effect of ATLS/PHTLS spinal motion restriction protocol on the incidence of spinal cord injury, a nationwide database study. Article Snippet: The statistical analyses were conducted using Article Title: District-level monitoring of universal health coverage, India Article Snippet: We used the Article Title: Associations between Global Diet Quality Score and Risk of Metabolic Syndrome and Its Components: Tehran Lipid and Glucose Study. Article Snippet: IBM SPSS software version 26 (IBM Co.), and STATA (StataCorp.) were used to analyze data. Article Title: Automated Comprehensive CT Assessment of the Risk of Diabetes and Associated Cardiometabolic Conditions. Article Snippet: Differences in the Article Title: Evening dosing versus morning dosing of antihypertensive medications for nocturnal hypertension: a systematic review and meta-analysis of 107 randomized controlled trials Article Snippet: All meta-analyses and meta-regressions were conducted using Article Title: Picking Up PrEP-Role of Clinician Specialty. Article Snippet: T here are approximately 1.2 million individuals in the US who are living with HIV, with around 34 800 incident HIV cases as of 2019.1,2 Preexposure prophylaxis (PrEP) has been proven to be associated with a reduced risk of HIV infection by 99% when taken as prescribed,3 but uptake has been suboptimal.. The US Centers for Disease Control and Prevention have suggested that an additional 1.2 million adults in the US have an indication for PrEP4; however, only approximately 224 000 received a PrEP prescription in 2019.5,6 Even after being prescribed PrEP, many patients do not or are unable to pick up their prescriptions from their pharmacies.. When a patient does not pick up an insurer-approved PrEP prescription at the pharmacy point of sale, the pharmacy returns it to stock and registers it as a prescription reversal. Article Title: Neo-adjuvant FOLFOX with and without panitumumab for patients with KRAS-wt locally advanced colon cancer: results following an extended biomarker panel on the FOxTROT Trial embedded phase II population. Article Snippet: Background The FOxTROT trial has reported advantages of neoadjuvant chemotherapy (NAC) in locally advanced colon cancer (LACC).. Here we present results of the embedded randomized phase II trial testing the addition of panitumumab to neoadjuvant FOLFOX compared with FOLFOX alone in RAS and BRAF-wild-type patients and with biomarker hyperselction.. Patients and Methods: Patients had operable, CT-predicted stage T3-4, N0-2, M0 colon adenocarcinoma. |